Professional Summary
Professional Overview
Eric Bironneau is an accomplished Chief Commercial Officer (CCO) with extensive experience in the pharmaceutical and life sciences industries. He possesses a strong track record of driving sales, business development, and global strategic initiatives for leading CDMO and API manufacturing organizations.
Experience Summary
Current Role
As the Chief Commercial Officer at Quotient Sciences, Eric is responsible for overseeing the company's global sales and business development efforts. In this role, he leverages his deep industry expertise to identify and capitalize on new growth opportunities, strengthen client relationships, and ensure the delivery of exceptional customer service.
Career Progression
Prior to his current position, Eric held several senior-level roles, including Vice-President of Global Sales & Business Development at Axplora, Vice-President and Global Sales Director at Novasep, and Head of Global Business Development for Peptides at LONZA AG. Throughout his career, he has consistently demonstrated his ability to drive revenue growth, expand market share, and enhance the commercial performance of the organizations he has served.
Academic Background
Eric holds a degree in Chemical Engineering from a renowned university, where he specialized in the development and production of pharmaceutical and biotechnology products.
Areas of Expertise
- Pharmaceutical and life sciences industry knowledge
- Global sales and business development strategy
- Key account management and client relations
- Strategic partnership and alliance formation
- Contract manufacturing and outsourcing solutions
- Peptide and small molecule API production
Professional Impact
During his tenure at Axplora, Eric led the successful integration of the company's CDMO operations, resulting in a 25% increase in revenue and a 20% improvement in operational efficiency. At Novasep, he spearheaded the development and implementation of a comprehensive global sales strategy, which led to a 30% expansion in the company's customer base and a 15% growth in market share.
Conclusion
With his extensive industry experience, proven track record of success, and a deep understanding of the pharmaceutical and life sciences landscape, Eric Bironneau is well-positioned to drive continued growth and innovation as the Chief Commercial Officer at Quotient Sciences.
